Cargando…

Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models

Neuromuscular junctions (NMJs) are specialized synapses responsible for signal transduction between motor neurons (MNs) and skeletal muscle tissue. Malfunction at this site can result from developmental disorders, toxic environmental exposures, and neurodegenerative diseases leading to severe neurol...

Descripción completa

Detalles Bibliográficos
Autores principales: Strickland, Julie B., Davis-Anderson, Katie, Micheva-Viteva, Sofiya, Twary, Scott, Iyer, Rashi, Harris, Jennifer Foster, Solomon, Emilia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805869/
https://www.ncbi.nlm.nih.gov/pubmed/35018825
http://dx.doi.org/10.1089/ten.teb.2021.0204
_version_ 1784862417864359936
author Strickland, Julie B.
Davis-Anderson, Katie
Micheva-Viteva, Sofiya
Twary, Scott
Iyer, Rashi
Harris, Jennifer Foster
Solomon, Emilia A.
author_facet Strickland, Julie B.
Davis-Anderson, Katie
Micheva-Viteva, Sofiya
Twary, Scott
Iyer, Rashi
Harris, Jennifer Foster
Solomon, Emilia A.
author_sort Strickland, Julie B.
collection PubMed
description Neuromuscular junctions (NMJs) are specialized synapses responsible for signal transduction between motor neurons (MNs) and skeletal muscle tissue. Malfunction at this site can result from developmental disorders, toxic environmental exposures, and neurodegenerative diseases leading to severe neurological dysfunction. Exploring these conditions in human or animal subjects is restricted by ethical concerns and confounding environmental factors. Therefore, in vitro NMJ models provide exciting opportunities for advancements in tissue engineering. In the last two decades, multiple NMJ prototypes and platforms have been reported, and each model system design is strongly tied to a specific application: exploring developmental physiology, disease modeling, or high-throughput screening. Directing the differentiation of stem cells into mature MNs and/or skeletal muscle for NMJ modeling has provided critical cues to recapitulate early-stage development. Patient-derived inducible pluripotent stem cells provide a personalized approach to investigating NMJ disease, especially when disease etiology cannot be resolved down to a specific gene mutation. Having reproducible NMJ culture replicates is useful for high-throughput screening to evaluate drug toxicity and determine the impact of environmental threat exposures. Cutting-edge bioengineering techniques have propelled this field forward with innovative microfabrication and design approaches allowing both two-dimensional and three-dimensional NMJ culture models. Many of these NMJ systems require further validation for broader application by regulatory agencies, pharmaceutical companies, and the general research community. In this summary, we present a comprehensive review on the current state-of-art research in NMJ models and discuss their ability to provide valuable insight into cell and tissue interactions. IMPACT STATEMENT: In vitro neuromuscular junction (NMJ) models reveal the specialized mechanisms of communication between neurons and muscle tissue. This site can be disrupted by developmental disorders, toxic environmental exposures, or neurodegenerative diseases, which often lead to fatal outcomes and is therefore of critical importance to the medical community. Many bioengineering approaches for in vitro NMJ modeling have been designed to mimic development and disease; other approaches include in vitro NMJ models for high-throughput toxicology screening, providing a platform to limit or replace animal testing. This review describes various NMJ applications and the bioengineering advancements allowing for human NMJ characteristics to be more accurately recapitulated. While the extensive range of NMJ device structures has hindered standardization attempts, there is still a need to harmonize these devices for broader application and to continue advancing the field of NMJ modeling.
format Online
Article
Text
id pubmed-9805869
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-98058692023-01-11 Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models Strickland, Julie B. Davis-Anderson, Katie Micheva-Viteva, Sofiya Twary, Scott Iyer, Rashi Harris, Jennifer Foster Solomon, Emilia A. Tissue Eng Part B Rev Review Articles Neuromuscular junctions (NMJs) are specialized synapses responsible for signal transduction between motor neurons (MNs) and skeletal muscle tissue. Malfunction at this site can result from developmental disorders, toxic environmental exposures, and neurodegenerative diseases leading to severe neurological dysfunction. Exploring these conditions in human or animal subjects is restricted by ethical concerns and confounding environmental factors. Therefore, in vitro NMJ models provide exciting opportunities for advancements in tissue engineering. In the last two decades, multiple NMJ prototypes and platforms have been reported, and each model system design is strongly tied to a specific application: exploring developmental physiology, disease modeling, or high-throughput screening. Directing the differentiation of stem cells into mature MNs and/or skeletal muscle for NMJ modeling has provided critical cues to recapitulate early-stage development. Patient-derived inducible pluripotent stem cells provide a personalized approach to investigating NMJ disease, especially when disease etiology cannot be resolved down to a specific gene mutation. Having reproducible NMJ culture replicates is useful for high-throughput screening to evaluate drug toxicity and determine the impact of environmental threat exposures. Cutting-edge bioengineering techniques have propelled this field forward with innovative microfabrication and design approaches allowing both two-dimensional and three-dimensional NMJ culture models. Many of these NMJ systems require further validation for broader application by regulatory agencies, pharmaceutical companies, and the general research community. In this summary, we present a comprehensive review on the current state-of-art research in NMJ models and discuss their ability to provide valuable insight into cell and tissue interactions. IMPACT STATEMENT: In vitro neuromuscular junction (NMJ) models reveal the specialized mechanisms of communication between neurons and muscle tissue. This site can be disrupted by developmental disorders, toxic environmental exposures, or neurodegenerative diseases, which often lead to fatal outcomes and is therefore of critical importance to the medical community. Many bioengineering approaches for in vitro NMJ modeling have been designed to mimic development and disease; other approaches include in vitro NMJ models for high-throughput toxicology screening, providing a platform to limit or replace animal testing. This review describes various NMJ applications and the bioengineering advancements allowing for human NMJ characteristics to be more accurately recapitulated. While the extensive range of NMJ device structures has hindered standardization attempts, there is still a need to harmonize these devices for broader application and to continue advancing the field of NMJ modeling. Mary Ann Liebert, Inc., publishers 2022-12-01 2022-12-09 /pmc/articles/PMC9805869/ /pubmed/35018825 http://dx.doi.org/10.1089/ten.teb.2021.0204 Text en © Julie B. Strickland, et al. 2022; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by-nc/4.0/This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License [CC-BY-NC] (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited.
spellingShingle Review Articles
Strickland, Julie B.
Davis-Anderson, Katie
Micheva-Viteva, Sofiya
Twary, Scott
Iyer, Rashi
Harris, Jennifer Foster
Solomon, Emilia A.
Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models
title Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models
title_full Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models
title_fullStr Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models
title_full_unstemmed Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models
title_short Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models
title_sort optimization of application-driven development of in vitro neuromuscular junction models
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805869/
https://www.ncbi.nlm.nih.gov/pubmed/35018825
http://dx.doi.org/10.1089/ten.teb.2021.0204
work_keys_str_mv AT stricklandjulieb optimizationofapplicationdrivendevelopmentofinvitroneuromuscularjunctionmodels
AT davisandersonkatie optimizationofapplicationdrivendevelopmentofinvitroneuromuscularjunctionmodels
AT michevavitevasofiya optimizationofapplicationdrivendevelopmentofinvitroneuromuscularjunctionmodels
AT twaryscott optimizationofapplicationdrivendevelopmentofinvitroneuromuscularjunctionmodels
AT iyerrashi optimizationofapplicationdrivendevelopmentofinvitroneuromuscularjunctionmodels
AT harrisjenniferfoster optimizationofapplicationdrivendevelopmentofinvitroneuromuscularjunctionmodels
AT solomonemiliaa optimizationofapplicationdrivendevelopmentofinvitroneuromuscularjunctionmodels